A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

Breathing—a natural and essential process—can be an incredibly labored process for people with cystic fibrosis. CF, a genetic ...

Anyone, of any ethnicity, can get cystic fibrosis. But for decades it has been overlooked in people of color, leading to misdiagnoses and dismal health disparities. Terry Wright takes a pulmonary ...

CBS News New York's John Elliott was at Hudson River Park on Wednesday, where the Cystic Fibrosis Foundation's Great Strides Walk got underway.

Cystic fibrosis is a genetic disorder that affects roughly 40,000 Americans. The condition is caused by a mutation in the patient's cystic fibrosis transmembrane conductance regulator (CFTR) gene, ...

The European Medicines Agency (EMA) recommended in its April meetings approval of marketing authorizations for two orphan medicines: Alyftrek for the treatment of cystic fibrosis and Attrogy for ...

States screen for cystic fibrosis (CF) but with significant variation among their screening algorithms. The Cystic Fibrosis Foundation group conducted a systematic review, leading to seven ...

Finding out your child has cystic fibrosis can feel like stepping into unfamiliar territory without a map. The medical terminology, treatment schedules, and long-term implications can overwhelm ...

The introduction of highly effective modulator (elexacaftor/tezacaftor/ivacaftor) therapy improved the disease trajectory of cystic fibrosis (CF). However, its ...

The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an ...

Perinatal dysfunction of innate immunity in cystic fibrosis. Science Translational Medicine , 2025; 17 (782) DOI: 10.1126/scitranslmed.adk9145 Cite This Page : ...

Please provide your email address to receive an email when new articles are posted on . Percent-predicted FEV 1, sweat chloride and safety were analyzed in two phase 3 trials of vanzacaftor ...